Postprandial Monocyte Maturation and Vascular Dysfunction Following High-Fat Meals - Study 1
1 other identifier
interventional
59
1 country
1
Brief Summary
The purpose of this research study is to examine the effect of high-fat meals on the health of blood vessels. In addition, the study will examine how exercise/fitness/physical activity impacts blood vessels after consumption of a high-fat meal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 17, 2019
CompletedFirst Posted
Study publicly available on registry
May 22, 2019
CompletedStudy Start
First participant enrolled
June 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 29, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 29, 2021
CompletedApril 13, 2022
April 1, 2022
1.9 years
May 17, 2019
April 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (20)
Fasting triglycerides
Ester derived from glycerol and three fatty acids, representative of the main constituent of body fat in humans.
Baseline
Post HFM Triglycerides
Ester derived from glycerol and three fatty acids, representative of the main constituent of body fat in humans.
4 hours
Fasting total cholesterol
Type of lipid that is required for cell structure, but can contribute to increased risk of heart disease if high due to development of fatty deposits on vascular wall.
Baseline
Post HFM total cholesterol
Type of lipid that is required for cell structure, but can contribute to increased risk of heart disease if high due to development of fatty deposits on vascular wall.
4 hours
Fasting LDL
Low density lipoprotein that transports fat molecules in the body. Associated with high levels of cholesterol.
Baseline
Post HFM LDL
Low density lipoprotein that transports fat molecules in the body. Associated with high levels of cholesterol.
4 hours
Fasting HDL
High density lipoprotein that transports fat molecules in the body. Associated with carrying cholesterol to the liver for degradation.
Baseline
Post HFM HDL
High density lipoprotein that transports fat molecules in the body. Associated with carrying cholesterol to the liver for degradation.
4 hours
Fasting non-HDL
Total cholesterol minus HDL, often associated with a better assessment of risk for heart disease.
Baseline
Post HFM non-HDL
Total cholesterol minus HDL, often associated with a better assessment of risk for heart disease.
4 hours
Fasting LDL/HDL ratio
Assessment of risk for heart disease.
Baseline
Post HFM LDL/HDL ratio
Assessment of risk for heart disease.
4 hours
Fasting anti-inflammatory surface receptor expression
CD14, CD206 - monocyte receptors associated with defining subsets and inflammatory differentiation of macrophages.
Baseline
Post HFM anti-inflammatory surface receptor expression
CD14, CD206 - monocyte receptors associated with defining subsets and inflammatory differentiation of macrophages.
4 hours
Fasting pro-inflammatory surface receptor expression
CD16, CD86 - monocyte receptors associated with defining subsets and inflammatory differentiation of macrophages.
Baseline
Post HFM pro-inflammatory surface receptor expression
CD16, CD86 - monocyte receptors associated with defining subsets and inflammatory differentiation of macrophages.
4 hours
Fasting brachial artery flow-mediated dilation
Dilation of brachial artery when blood flow increases in artery. Measured by non-invasive ultrasound.
Baseline
Post HFM brachial artery flow-mediated dilation
Dilation of brachial artery when blood flow increases in artery. Measured by non-invasive ultrasound.
5.5 hours
Fasting superficial artery flow-mediated dilation
Dilation of superficial artery when blood flow increases in artery. Measured by non-invasive ultrasound.
Baseline
Post HFM superficial artery flow-mediated dilation
Dilation of superficial artery when blood flow increases in artery. Measured by non-invasive ultrasound.
5.5 hours
Study Arms (2)
Low physical activity/fitness
OTHERParticipants will be classified as into low-physical fitness based on self-reported physical activity and cardiorespiratory fitness testing.
High physical activity/fitness
OTHERParticipants will be classified as into high-physical fitness based on self-reported physical activity and cardiorespiratory fitness testing.
Interventions
Participants will be given a serving of Marie Callendar's Chocolate Satin Pie to eat over a period of 20 minutes
Eligibility Criteria
You may qualify if:
- college-age: 18-30 years old
- normal fasting triglyceride (\<150 mg/dL) (American College of Sports Medicine Guidelines for Exercise Testing and Prescription, 10th Edition).
- normal body composition: % body fat, males \<25%, females \<32% (American College of Sports Medicine Guidelines for Exercise Testing and Prescription, 10th Edition)
- self-reported engagement in moderate-vigorous intensity physical activity and/or an exercise training regimen OR self-reported low physical activity and no engagement in an exercise training regimen (International Physical Activity Questionnaire)
- low cardiorespiratory fitness (VO2peak; male: =\<45 mL/kg/min; female: =\<35 mL/kg/min; categorized as =40th percentile by ACSM Guidelines for Exercise Testing and Prescription, 10th Edition; 44, 45, 46, 47) OR high cardiorespiratory fitness (VO2peak; male: =55 mL/kg/min; female: 45 mL/kg/min; categorized as =70th percentile by ACSM Guidelines for Exercise Testing and Prescription, 10th Edition; 44, 45, 46, 47)
- f.) for female participants, presence of a normal, monthly menstrual cycle with or without prescribed contraceptive methods.
You may not qualify if:
- presence of diagnosed cardiovascular, metabolic, or renal disease or dysfunction
- presence of signs and symptoms suggestive of cardiovascular, metabolic, or renal disease
- presence of musculoskeletal injury
- pregnancy
- history of smoking
- engagement in an abnormal eating behavior
- unable to communicate effectively in English
- moderate cardiorespiratory fitness (VO2peak; male: 46-54 mL/kg/min; female: 36-44 mL/kg/min)
- elevated or high fasting triglycerides (\>150 mg/dL)
- absence of a normal, monthly menstrual cycle with or without prescribed contraceptive methods
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Virginia Commonwealth Universitylead
- Sigma Xicollaborator
Study Sites (1)
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert L Franco, PhD
Virginia Commonwealth University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 17, 2019
First Posted
May 22, 2019
Study Start
June 17, 2019
Primary Completion
April 29, 2021
Study Completion
April 29, 2021
Last Updated
April 13, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share